HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer

Documenti analoghi

• Prognostic and Predictive Markers for Early Stage Triple‐Negative Breast Cancer Treated With Platinum‐Based Neoadjuvant Chemotherapy
  di: Zhenhui Zhao, et al.
  Pubblicazione: (2024)
• Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple‐Negative Breast Cancer Patients
  di: Fengling Li, et al.
  Pubblicazione: (2024)
• Correction to “RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy”
  Pubblicazione: (2025)
• USP15 Promotes Pancreatic Cancer Progression and Cisplatin Resistance By Activating DNA Damage Repair
  di: Zhigang Ma, et al.
  Pubblicazione: (2026)
• Translational Aspects of DNA Damage Repair in Optimizing Cancer Chemotherapy
  di: Anqi Lin, et al.
  Pubblicazione: (2025)